Wei Zhang, Mei Yee Koh, Deepika Sirohi, Jian Ying, Ben J. Brintz, Beatrice S. Knudsen
J Pathol Inform. 2023; 14: 100196

Multiplex Panels developed by the Knudsen lab

ONECUT2 AND CELL PLASTICITY IN PROSTATE CANCER
Racial disparities in ONECUT2 – KAISO interactions with clinical significance
Collaborator: Michael R. Freeman - Cedars Sinai Medical Center
Sophia Akinbo Masters student in the Master of Science in Laboratory Medicine and Biomedical Science Program

Nature Medicine 2018 - ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the
androgen axis
bioRiv 2023 - ONECUT2 Activates Diverse Resistance Drivers of Androgen Receptor-Independent Heterogeneity in Prostate Cancer
CHROMOSOMAL INSTABILITY & DNA DAMAGE REPAIR IN PROSTATE CANCER
Collaborator: Anne Cress – University of Arizona
